The FY2025 (Sep) proxy of Enanta Pharmaceuticals names 21 peer companies for pay. Among Enanta Pharmaceuticals and these peers, CEO pay was 8th highest of 11 and total shareholder return was 8th highest of 11.
8th highest of 11in Enanta Pharmaceuticals and its pay peers, FY2025 (Sep) by CEO pay:
$1.4M$8.5M
8th highest of 11in Enanta Pharmaceuticals and its pay peers, FY2025 (Sep) by total shareholder return:
$9$206
Pay peer group, FY2025 (Sep) proxy
| Travere Therapeutics | ||
| Altimmune | ||
| Nektar Therapeutics | ||
| Rigel Pharmaceuticals | ||
| Regenxbio | ||
| Vanda Pharmaceuticals | ||
| Lexicon Pharmaceuticals | ||
| Editas Medicine | ||
| Inovio Pharmaceuticals | ||
| Arbutus Biopharma | ||
| Allogene Therapeutics | Not disclosed | Not disclosed |
| Arcturus Therapeutics Holdings | Not disclosed | Not disclosed |
| Heron Therapeutics | Not disclosed | Not disclosed |
| Karyopharm Therapeutics | Not disclosed | Not disclosed |
| Macrogenics | Not disclosed | Not disclosed |
| Omeros | Not disclosed | Not disclosed |
| Puma Biotechnology | Not disclosed | Not disclosed |
| Sage Therapeutics | Not disclosed | Not disclosed |
| Sangamo Pharmaceuticals | Not disclosed | Not disclosed |
| Sutro Biopharma | Not disclosed | Not disclosed |
| Theravance Biopharma | Not disclosed | Not disclosed |
21 companies
Changes by year
FY2025 (Sep) proxy
- AddedAllogene Therapeuticspay peer group
- AddedAltimmunepay peer group
- AddedEditas Medicinepay peer group
- AddedInovio Pharmaceuticalspay peer group
- AddedNektar Therapeuticspay peer group
- AddedPuma Biotechnologypay peer group
- AddedRigel Pharmaceuticalspay peer group
- AddedSage Therapeuticspay peer group
- AddedSutro Biopharmapay peer group
- RemovedAgiospay peer groupbecause they had been acquired
- RemovedAllovirpay peer groupbecause they had been acquired
- RemovedBioCrystpay peer groupbecause they had been acquired
- RemovedDecipherapay peer groupbecause they had been acquired
- RemovedFibroGenpay peer groupbecause they had been acquired
- RemovedInterceptpay peer groupbecause they had been acquired
- RemovedLigandpay peer groupbecause they had been acquired
- RemovedSupernuspay peer groupbecause they had been acquired
- RemovedXencorpay peer groupbecause they had been acquired
FY2024 (Sep) proxy
- AddedArcturuspay peer group
- AddedLexiconpay peer group
- RemovedAmicus Therapeuticspay peer groupdue to their being outside of our market capitalization or revenue criteria
- RemovedCorcept Therapeuticspay peer groupdue to their being outside of our market capitalization or revenue criteria
- RemovedImmunoGenpay peer groupdue to their being outside of our market capitalization or revenue criteria
- RemovedINSMEDpay peer groupdue to their being outside of our market capitalization or revenue criteria
- RemovedMadrigal Pharmaceuticalspay peer groupdue to their being outside of our market capitalization or revenue criteria
- RemovedPTC Therapeuticspay peer groupdue to their being outside of our market capitalization or revenue criteria
- RemovedVir Biotechnologypay peer groupdue to their being outside of our market capitalization or revenue criteria
FY2023 (Sep) proxy
- AddedAllovirpay peer groupBased on the revised criteria, our Compensation Committee added Allovir, Arbutus Biopharma, Arcturus Therapeutics, Deciphera Pharmaceuticals, MacroGenics and Omeros to our peer group for 2023
- AddedArbutus Biopharmapay peer groupBased on the revised criteria, our Compensation Committee added Allovir, Arbutus Biopharma, Arcturus Therapeutics, Deciphera Pharmaceuticals, MacroGenics and Omeros to our peer group for 2023
- AddedArcturus Therapeutics Holdingspay peer groupBased on the revised criteria, our Compensation Committee added Allovir, Arbutus Biopharma, Arcturus Therapeutics, Deciphera Pharmaceuticals, MacroGenics and Omeros to our peer group for 2023
- AddedDeciphera Pharmaceuticalspay peer groupBased on the revised criteria, our Compensation Committee added Allovir, Arbutus Biopharma, Arcturus Therapeutics, Deciphera Pharmaceuticals, MacroGenics and Omeros to our peer group for 2023
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.